According to the analytical company Alpha Research and Marketing, the Russian pharmacy segment amounted to 94.5 billion rubles in sellout prices in January 2017. It grew by 17% compared to January of last year in national currency. However, due to currency fluctuations, the growth compared to last year’s January amounted to 53% in US dollars and 56% in European currency. The decrease in sales volumes in January compared to the previous month was logical: this decrease amounted to 12% in rubles, 8 and 9% in dollars and euro, respectively.
The largest share in sales amounts to 31% and belongs to the Central Federal District, followed by Volga federal district, North-West and Siberian federal districts with 19%, 12% and 12% respectively. The leaders in the Central Federal District are Moscow and Moscow region with 13% and 6% respectively. In the Volga district, the leadership is shared by Nizhny Novgorod region, Samara region and the Republic of Tatarstan with 2.5% each. In the North-West Federal District, St. Petersburg is the leader with 6%. In the Siberian Federal District, the Novosibirsk region stands out with 2.3%, and the Krasnoyarsk Territory with 2%.
The largest increase in sales was observed in the Ural and Volga federal district, where the increase in rubles in January 2017 compared to January 2016 amounted to 25 and 23%, respectively. In foreign currency, these results reached 63 and 61% in US dollars and 66 and 64% in European currency. There was not one federal region in which retail sales of medicinal products would decrease. However, there was a slight decline in sales in rubles in some regions: the Nenets Autonomous District, the Altai Territory and the Arkhangelsk Region. In these constituent entities of the Russian Federation, the sales fell by 8, 4 and 3%, respectively.
According to the analytical company Alpha Research and Marketing, the Russian pharmacy segment amounted to 94.5 billion rubles in sellout prices in January 2017. It grew by 17% compared to January of last year in national currency. However, due to currency fluctuations, the growth compared to last year’s January amounted to 53% in US dollars and 56% in European currency. The decrease in sales volumes in January compared to the previous month was logical: this decrease amounted to 12% in rubles, 8 and 9% in dollars and euro, respectively.
The largest share in sales amounts to 31% and belongs to the Central Federal District, followed by Volga federal district, North-West and Siberian federal districts with 19%, 12% and 12% respectively. The leaders in the Central Federal District are Moscow and Moscow region with 13% and 6% respectively. In the Volga district, the leadership is shared by Nizhny Novgorod region, Samara region and the Republic of Tatarstan with 2.5% each. In the North-West Federal District, St. Petersburg is the leader with 6%. In the Siberian Federal District, the Novosibirsk region stands out with 2.3%, and the Krasnoyarsk Territory with 2%.
The largest increase in sales was observed in the Ural and Volga federal district, where the increase in rubles in January 2017 compared to January 2016 amounted to 25 and 23%, respectively. In foreign currency, these results reached 63 and 61% in US dollars and 66 and 64% in European currency. There was not one federal region in which retail sales of medicinal products would decrease. However, there was a slight decline in sales in rubles in some regions: the Nenets Autonomous District, the Altai Territory and the Arkhangelsk Region. In these constituent entities of the Russian Federation, the sales fell by 8, 4 and 3%, respectively.
Author: «Pharmacevtichesky vestnik»